Medical technology company RaySearch Laboratories AB (publ) (STO:RAY-B) announced on Friday the appointment of Nina Grönberg as the new chief financial officer, effective 27 January 2025.
With extensive experience in finance leadership roles at various international publicly listed companies, Nina most recently served as CFO at Team Olivia and held previous CFO positions at Duroc. Additionally, she has contributed to accounting, reporting, and business control at Ratos and Munters.
Nina Grönberg says: "RaySearch is an innovative company and a driving force in the fight against cancer. The finance function has an important role to play in this exciting phase of expansion that RaySearch is currently undergoing."
Neogap Therapeutics partners with NorthX Biologics to enhance cancer cell therapy production
Medivir partners with Eisai to evaluate fostrox in liver cancer
OSE Immunotherapeutics' Lusvertikimab shows promise in ulcerative colitis
Cytoki Pharma doses first patient with CK-0045 in Phase two proof-of-concept trial
Amphix Bio receives USD1m SBIR Phase II grant from National Science Foundation
Bexion Pharmaceuticals reports release of first-in-human data from Phase 1 study of BXQ-350
Eisai completes rolling BLA submission for lecanemab-irmb to FDA
Boehringer Ingelheim discontinues development of NYP2 agonist